Weighted Average Number of Shares Outstanding, Basic of Aldeyra Therapeutics, Inc. from 31 Mar 2013 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aldeyra Therapeutics, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2013 to 31 Dec 2025.
  • Aldeyra Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 60,056,557, a 0.96% increase year-over-year.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2025 was 60,056,557, a 0.96% increase from 2024.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 59,484,794, a 0.92% increase from 2023.
  • Aldeyra Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 58,943,205, a 0.92% increase from 2022.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Aldeyra Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 60,056,557 +571,763 +0.96% 01 Oct 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 60,126,850 +596,737 +1% 01 Jul 2025 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 60,045,530 +631,041 +1.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 59,887,277 +472,788 +0.8% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 59,484,794 +541,589 +0.92% 01 Oct 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 59,530,113 +539,924 +0.92% 01 Jul 2024 30 Sep 2024 10-Q 05 Nov 2025 2025 Q3
Q2 2024 59,414,489 +622,569 +1.1% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025 2025 Q2
Q1 2024 59,414,489 +622,886 +1.1% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025 2025 Q1
Q4 2023 58,943,205 +537,308 +0.92% 01 Oct 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 58,990,189 +532,326 +0.91% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 58,791,920 +490,429 +0.84% 01 Apr 2023 30 Jun 2023 10-Q 01 Aug 2024 2024 Q2
Q1 2023 58,791,603 +493,742 +0.85% 01 Jan 2023 31 Mar 2023 10-Q 02 May 2024 2024 Q1
Q4 2022 58,405,897 01 Oct 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 58,457,863 +438,764 +0.76% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 58,301,491 +4,021,098 +7.4% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 58,297,861 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q3 2021 58,019,099 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 54,280,393 01 Apr 2021 30 Jun 2021 10-Q 05 Aug 2022 2022 Q2
Q1 2016 9,712,521 +3,045,002 +46% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 8,633,897 +4,815,740 +126% 01 Oct 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
Q3 2015 9,712,521 +4,147,106 +75% 01 Jul 2015 30 Sep 2015 10-Q 13 Nov 2015 2015 Q3
Q2 2015 8,397,713 +4,660,038 +125% 01 Apr 2015 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 6,667,519 +6,340,154 +1937% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016 2016 Q1
Q4 2014 3,818,157 +3,499,728 +1099% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q3 2014 5,565,415 +5,248,040 +1654% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015 2015 Q3
Q2 2014 3,737,675 +3,423,256 +1089% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015 2015 Q2
Q1 2014 327,365 +12,946 +4.1% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015 2015 Q1
Q4 2013 318,429 01 Oct 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
Q3 2013 317,375 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2014 2014 Q3
Q2 2013 314,419 01 Apr 2013 30 Jun 2013 10-Q 07 Aug 2014 2014 Q2
Q1 2013 314,419 01 Jan 2013 31 Mar 2013 10-Q 11 Jun 2014 2014 Q1

Aldeyra Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 60,056,557 +571,763 +0.96% 01 Jan 2025 31 Dec 2025 10-K 27 Feb 2026 2025 FY
2024 59,484,794 +541,589 +0.92% 01 Jan 2024 31 Dec 2024 10-K 27 Feb 2026 2025 FY
2023 58,943,205 +537,308 +0.92% 01 Jan 2023 31 Dec 2023 10-K 28 Feb 2025 2024 FY
2022 58,405,897 +4,363,794 +8.1% 01 Jan 2022 31 Dec 2022 10-K 07 Mar 2024 2023 FY
2021 54,042,103 01 Jan 2021 31 Dec 2021 10-K 09 Mar 2023 2022 FY
2015 8,633,897 +4,815,740 +126% 01 Jan 2015 31 Dec 2015 10-K 30 Mar 2016 2015 FY
2014 3,818,157 +3,499,728 +1099% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016 2015 FY
2013 318,429 01 Jan 2013 31 Dec 2013 10-K 23 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.